NGM BIOPHARMACEUTICALS INC
CUSIP 62921N105
Ngm Biopharmaceuticals Inc has 112 institutional holders in Filings Flow’s 13F database, together reporting 39.16M shares worth $188M as of Q4 2022.
Institutional Holders
112
Q4 2022
Reported Value
$188M
Ticker
unmapped
private placement or foreign
Quarters Tracked
5
Ownership Trend
Institutional holders
Total reported value
Holders
| Manager | % of Portfolio | Value | Shares | Quarter |
|---|---|---|---|---|
| Legal & General Group Plc$432.4B AUM | 0.00% | $2,602 | 3.0K | Q1 2025 |
Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.